BiTrial CRO | Poland

Poland is a large Central European country with a rich historical legacy, known for its vibrant cities, medieval architecture, and diverse landscapes. As a key EU member, Poland has rapidly modernized its infrastructure, becoming an economic leader in the region.

European Union (EU) member since 2004

Total population: 37.843.188*(2026)

BiTrial in Poland

Poland is a major hub for clinical trials in Central Europe, offering a high standard of medical care and a large, diverse population. The country has efficient regulatory approval processes and competitive trial costs. Its robust healthcare system supports high-quality research.

📊 Is Poland good for clinical research?

Decades of producing high-quality data recognized by regulatory authorities, including the FDA and EMA.

Large, diverse population with a strong willingness to participate in clinical trials.

Wide range of therapeutic areas and access to specialized patient groups.

Highly skilled, motivated investigators and site staff across the country.

Extensive network of specialized medical facilities in major urban centres.